News

Published on 9 May 2024 on Benzinga via Yahoo Finance

What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?


Article preview image

What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?

On Thursday, RAPT Therapeutics Inc. (NASDAQ:RAPT) announced that it has decided to close and unblind both its Phase 2b trial of zelnecirnon (RPT193) in atopic dermatitis (AD) and its Phase 2a trial of zelnecirnon in asthma.

Both clinical trials were placed on clinical hold by the FDA in February 2024 based on a serious adverse event of liver failure requiring a transplant in one patient in the AD trial.

NASDAQ.RAPT price evolution
NASDAQ.REED price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
The best movie musicals of all time, from Singin' in the Rain to Grease

With...at the onslaught of pop star concert documentaries with a self-referential comedy about a...

Yahoo Movies UK 25 Nov 2024

Musk says he and Trump have 'mandate to delete' regulations. Ethics laws could...

In picking billionaire Elon Musk to be “our cost cutter” for the U.S. government, President-elect...

WFMZ Eastern Pennsylvania and Western New Jersey 17 Nov 2024

Decatur community theater group returns to the Richland stage

Director Michelle Stephens started the theater program after a six-year gap. The newest cast will...

Herald & Review 13 Nov 2024

Elon Musk's PAC spent an estimated $200 million to help elect Trump, AP source...

Elon Musk's super PAC spent about $200 million to help elect Donald Trump, according to a person...

Winston-Salem Journal 12 Nov 2024

Elon Musk's PAC spent an estimated $200 million to help elect Trump, AP source...

Elon Musk's super PAC spent about $200 million to help elect Donald Trump, according to a person...

Quad-City Times 12 Nov 2024

JPMorgan execs call for unity in a memo to staff on Trump's victory

JPMorgan CEO Jamie Dimon congratulated Donald Trump on winning the White House. In a memo to staf...

Business Insider 6 Nov 2024

Origin materials CFO sells shares worth $157,860 By Investing.com

Origin Materials, Inc. (NASDAQ:ORGN) recently reported that its Chief Financial Officer, Matthew ...

Investing.com 6 Nov 2024

Insider Trading Roundup: Monday's Top Buys and Sells in US Stocks By...

Insider Trading Roundup: Monday's Top Buys and Sells in US Stocks

Investing.com 5 Nov 2024

Netflix executive chairman Reed Hastings sells $31.5 million in stock By...

Reed Hastings, Executive Chairman of Netflix Inc. (NASDAQ:NFLX), disclosed significant stock...

Investing.com 5 Nov 2024

The Typical American Can't Name the Companies Behind These Popular Brands

National Amusements is just a movie theater operating company with 71 theaters in North and South...

247wallst.com 4 Nov 2024